title: The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes.
authors: Cardiovascular Research Center, St George's University of London, London SW17 0RE, UK. ebehr@sgul.ac.uk
authors: Elijah R
authors: ER
authors: Behr
authors: Craig
authors: C
authors: January
authors: Eric
authors: E
authors: Schulze-Bahr
authors: Andrew A
authors: AA
authors: Grace
authors: Stefan
authors: S
authors: Kääb
authors: Monica
authors: M
authors: Fiszman
authors: Shaniece
authors: S
authors: Gathers
authors: Shaavhrée
authors: S
authors: Buckman
authors: Ashraf
authors: A
authors: Youssef
authors: Munir
authors: M
authors: Pirmohamed
authors: Dan
authors: D
authors: Roden
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D032921:Consensus; D003245:Consensus Statements as Topic; D064420:Drug-Related Side Effects and Adverse Reactions / Q000235:genetics; D005819:Genetic Markers; D005820:Genetic Testing / Q000379:methods; D006633:Histamine Antagonists / Q000009:adverse effects; D006801:Humans; D007400:Interprofessional Relations; D010641:Phenotype; D012307:Risk Factors; D012737:Sex Factors; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics
chemical_list: D000889:Anti-Arrhythmia Agents; D000890:Anti-Infective Agents; D014150:Antipsychotic Agents; D005819:Genetic Markers; D006633:Histamine Antagonists